Cargando…
Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostatics
Combination chemotherapy has proven to be a favorable strategy to treat acute leukemia. However, the introduction of novel compounds remains challenging and is hindered by a lack of understanding of their mechanistic interactions with established drugs. In the present study, we demonstrate a highly...
Autores principales: | Koczian, Fabian, Nagło, Olga, Vomacka, Jan, Vick, Binje, Servatius, Phil, Zisis, Themistoklis, Hettich, Britta, Kazmaier, Uli, Sieber, Stephan A., Jeremias, Irmela, Zahler, Stefan, Braig, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395311/ https://www.ncbi.nlm.nih.gov/pubmed/30309851 http://dx.doi.org/10.3324/haematol.2018.197368 |
Ejemplares similares
-
Synthesis and late stage modifications of Cyl derivatives
por: Servatius, Phil, et al.
Publicado: (2022) -
A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
por: Kellner, Markus, et al.
Publicado: (2022) -
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A
por: Zhang, Siwei, et al.
Publicado: (2015) -
Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers
por: Meßner, Martina, et al.
Publicado: (2021) -
Prime-seq, efficient and powerful bulk RNA sequencing
por: Janjic, Aleksandar, et al.
Publicado: (2022)